GL1X · GenesisL1 explorer

Research workbench

Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir

Analyse Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2NNP
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P04587
Ligands
ROC, SO4
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 57% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein997% helix, 57% strandP04587

Ligands and binding sites

  • ROC · (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1 -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide · ligand · chains A, B
  • SO4 · Sulfate ion · ion · chains B
  • ACY · Acetic acid · additive · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14070.720.8334ROC

Interfaces

1 interface between chains.

  • A–B · 1814 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 2NNP · Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.